Clinical Microbiology and Infection

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Clinical Microbiology and Infection
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.
Gram-positive infections: lessons learnt and novel solutions
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus.
Clinical Microbiology and Infection
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections 
G. Cornaglia, A. Lönnroth, M. Struelens 
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
A. Simon, U. Bode, K. Beutel  Clinical Microbiology and Infection 
Clinical impact of antibiotic-resistant Gram-positive pathogens
Cost-effectiveness of universal MRSA screening on admission to surgery
N. Messad, L. Landraud, B. Canivet, G. Lina, J. -L. Richard, A
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals 
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
J.-P. Stahl  Clinical Microbiology and Infection 
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O.
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Treatment of staphylococcal infections with cyclic lipopeptides
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis  O. Lesens, F. Desbiez, M. Vidal,
G. Sakoulas  Clinical Microbiology and Infection 
Do we need new antibiotics?
L.R. Peterson  Clinical Microbiology and Infection 
A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V  K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia  A. Budimir, R.H. Deurenberg, Z. Bošnjak,
Bacterial resistance—the clinical challenge
Strategies for managing today's infections
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis  R. Diaz, V. Afreixo,
Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.
Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections 
Levofloxacin in the treatment of ventilator-associated pneumonia
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals  E.E. Udo, N. Al-Sweih, B.
Recent developments in staphylococcal scalded skin syndrome
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study  V.
Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated.
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
A.W. Karchmer  Clinical Microbiology and Infection 
P.M. Hawkey  Clinical Microbiology and Infection 
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan 
Reducing antibiotic use in influenza: challenges and rewards
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Can pharmacokinetic–pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?  P. Courvalin  Clinical Microbiology and.
Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin.
Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
E. Tacconelli  Clinical Microbiology and Infection 
Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus  J.A.
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci  V. Sakka, S. Tsiodras, L. Galani, A. Antoniadou,
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
Test results: characterising the antimicrobial activity of daptomycin
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
J. Segreti  Clinical Microbiology and Infection 
The future of diagnostic bacteriology
Presentation transcript:

Clinical Microbiology and Infection Treatment challenges in the management of complicated skin and soft-tissue infections  B.I. Eisenstein  Clinical Microbiology and Infection  Volume 14, Pages 17-25 (March 2008) DOI: 10.1111/j.1469-0691.2008.01922.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Infected leg ulcer. The patient presented with an infected leg ulcer, the cause of which, methicillin-resistant Staphylococcus aureus, was identified on day 3. Daptomycin therapy was commenced on day 3, and less slough tissue was observed on day 5. Although the treatment was interrupted by the patient between days 7 and 10, recommencement of treatment on day 10 led to noticeable wound healing by day 12. Antibiotic therapy was stopped on day 14, and complete healing of the wound had occurred by day 21. Clinical Microbiology and Infection 2008 14, 17-25DOI: (10.1111/j.1469-0691.2008.01922.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Infected diabetic foot. The patient presented with an infected ulcer on the tip of the fourth toe of the left foot. The patient was hospitalised following assessment by a diabetologist, and initial wound debridement and cultures revealed methicillin-susceptible Staphylococcus aureus and group B β-haemolytic streptococci. Initial antibiotic treatment of the ulcer had no effect on the infection, and further treatment with vancomycin also resulted in insufficient regression of the infection (a). Treatment with daptomycin was commenced and resulted in reduction in the swelling and absence of putrid secretions after 2 days (b). Amputation of the fourth toe was performed on day 10 after admission (day 3 of therapy with daptomycin), and uncomplicated primary wound healing occurred after amputation; daptomycin was discontinued after 7 days (c). Clinical Microbiology and Infection 2008 14, 17-25DOI: (10.1111/j.1469-0691.2008.01922.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions